NLS Pharmaceutics to Participate in the SACHS 15th Annual European Life Sciences Virtual CEO Forum and a Fireside Chat with Maxim Analyst in MarchAccesswire • 02/25/22
NLS Pharmaceutics to Present Interim Top-Line Data for Quilience(R) (Mazindol ER) in Patients with Narcolepsy at the World Sleep Congress in March 2022Accesswire • 02/07/22
NLS Pharmaceutics Invites Patients, Caregivers and Other Interested Parties to Attend International Narcolepsy WebinarAccesswire • 01/12/22
NLS Pharmaceutics Announces Patent Issuance in the United States for its Mazindol Extended-Release FormulationAccesswire • 01/04/22
NLS Pharmaceutics Announces Preclinical Results Confirming the Potential Benefit and Safety Profile of NLS-4 for Circadian Rhythm Dysregulation and Chronic Fatigue Syndrome in Long-Covid ModelAccesswire • 11/30/21
NLS Pharmaceutics Announces Preclinical Data Demonstrating the Potential of NLS-4 (Lauflumide) to Treat Chronic Fatigue Associated With Long-COVIDAccesswire • 10/14/21
NLS Pharmaceutics to Participate in The Micro Cap Rodeo Fall Harvest Conference: Best Ideas from the Buy-sideAccesswire • 09/30/21
NLS Pharmaceutics Announces $20 Million Standby Equity Distribution Agreement and $2.5 Million Equity InvestmentAccesswire • 09/28/21
NLS Initiates Phase 2 Trial for Quilience in Narcolepsy and Announces First Patient EnrolledAccesswire • 09/14/21
NLS Pharmaceutics to Participate in the 23rd Annual H.C. Wainwright Global Investment ConferenceAccesswire • 09/08/21
NLS Pharmaceutics Announces Notice of Allowance for U.S. Patent Application Covering its Proprietary Mazindol FormulationAccesswire • 08/19/21
NLS Pharmaceutics to Participate in the Canaccord Genuity 41st Annual Growth ConferenceAccesswire • 08/05/21
NLS Pharmaceutics Announces the Appointment of Eric Konofal, M.D., Ph.D. as Chief Scientific OfficerAccesswire • 07/19/21
NLS Pharmaceutics Announces FDA Acceptance of IND Application to Initiate Clinical Trials with Quilience(R) (mazindol ER) to Treat NarcolepsyAccesswire • 07/15/21
NLS Pharmaceutics to Present at the Access to Giving Virtual Investor Conference on July 15thAccesswire • 07/09/21
NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021PRNewsWire • 06/02/21
NLS Pharmaceutics to Present at The MicroCap Rodeo 2021 Summer Solstice: Best Ideas from the Buyside Conference on June 1PRNewsWire • 05/28/21